These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 29551259)

  • 1. Ambulatory capacity in Japanese patients with Duchenne muscular dystrophy.
    Awano H; Itoh C; Takeshima Y; Lee T; Matsumoto M; Kida A; Kaise T; Suzuki T; Matsuo M
    Brain Dev; 2018 Jun; 40(6):465-472. PubMed ID: 29551259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knee Strength and Ankle Range of Motion Impacts on Timed Function Tests in Duchenne Muscular Dystrophy: In the Era of Glucocorticoids.
    Duong T; Canbek J; Fernandez-Fernandez A; Henricson E; Birkmeier M; Siener C; Tesi Rocha C; McDonald C; Gordish-Dressman H;
    J Neuromuscul Dis; 2022; 9(1):147-159. PubMed ID: 34719507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ambulatory capacity and disease progression as measured by the 6-minute-walk-distance in Duchenne muscular dystrophy subjects on daily corticosteroids.
    Goemans N; van den Hauwe M; Wilson R; van Impe A; Klingels K; Buyse G
    Neuromuscul Disord; 2013 Aug; 23(8):618-23. PubMed ID: 23770101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective Analysis of Fractures and Factors Causing Ambulation Loss After Lower Limb Fractures in Duchenne Muscular Dystrophy.
    Yildiz S; Glanzman AM; Estilow T; Flickinger J; Brandsema JF; Tennekoon G; Banwell BL; Yum S
    Am J Phys Med Rehabil; 2020 Sep; 99(9):789-794. PubMed ID: 32195737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lower extremity joint contracture according to ambulatory status in children with Duchenne muscular dystrophy.
    Choi YA; Chun SM; Kim Y; Shin HI
    BMC Musculoskelet Disord; 2018 Aug; 19(1):287. PubMed ID: 30111310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two-Year Longitudinal Changes in Lower Limb Strength and Its Relation to Loss in Function in a Large Cohort of Patients With Duchenne Muscular Dystrophy.
    Batra A; Harrington A; Lott DJ; Willcocks R; Senesac CR; McGehee W; Xu D; Mathur S; Daniels MJ; Rooney WD; Forbes SC; Triplett W; Deol JK; Arpan I; Bendixen R; Finkel R; Finanger E; Tennekoon G; Byrne B; Russman B; Sweeney HL; Walter G; Vandenborne K
    Am J Phys Med Rehabil; 2018 Oct; 97(10):734-740. PubMed ID: 29734234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can Quantitative Muscle Strength and Functional Motor Ability Differentiate the Influence of Age and Corticosteroids in Ambulatory Boys with Duchenne Muscular Dystrophy?
    Buckon C; Sienko S; Bagley A; Sison-Williamson M; Fowler E; Staudt L; Heberer K; McDonald CM; Sussman M
    PLoS Curr; 2016 Jul; 8():. PubMed ID: 27500011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Longitudinal Study of Quantitative Muscle Strength and Functional Motor Ability in Ambulatory Boys with Duchenne Muscular Dystrophy.
    Buckon CE; Sienko SE; Fowler EG; Bagley AM; Staudt LA; Sison-Williamson M; Heberer KR; McDonald CM; Sussman MD
    J Neuromuscul Dis; 2022; 9(2):321-334. PubMed ID: 34924398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of percentile curves for strength and functional abilities for boys with Duchenne muscular dystrophy.
    Leon MAS; Roza DLD; Davoli GBQ; Baptista CRJA; Sobreira CFDR; Mattiello-Sverzut AC
    Muscle Nerve; 2023 Aug; 68(2):198-205. PubMed ID: 37318179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural History of Steroid-Treated Young Boys With Duchenne Muscular Dystrophy Using the NSAA, 100m, and Timed Functional Tests.
    Miller NF; Alfano LN; Iammarino MA; Connolly AM; Moore-Clingenpeel M; Powers BR; Tsao CY; Waldrop MA; Flanigan KM; Mendell JR; Lowes LP
    Pediatr Neurol; 2020 Dec; 113():15-20. PubMed ID: 32979653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Categorizing natural history trajectories of ambulatory function measured by the 6-minute walk distance in patients with Duchenne muscular dystrophy.
    Mercuri E; Signorovitch JE; Swallow E; Song J; Ward SJ; ;
    Neuromuscul Disord; 2016 Sep; 26(9):576-83. PubMed ID: 27423700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of vamorolone in Duchenne muscular dystrophy: An 18-month interim analysis of a non-randomized open-label extension study.
    Smith EC; Conklin LS; Hoffman EP; Clemens PR; Mah JK; Finkel RS; Guglieri M; Tulinius M; Nevo Y; Ryan MM; Webster R; Castro D; Kuntz NL; Kerchner L; Morgenroth LP; Arrieta A; Shimony M; Jaros M; Shale P; Gordish-Dressman H; Hagerty L; Dang UJ; Damsker JM; Schwartz BD; Mengle-Gaw LJ; McDonald CM;
    PLoS Med; 2020 Sep; 17(9):e1003222. PubMed ID: 32956407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The natural history of the patients with Duchenne muscular dystrophy in Taiwan: A medical center experience.
    Liang WC; Wang CH; Chou PC; Chen WZ; Jong YJ
    Pediatr Neonatol; 2018 Apr; 59(2):176-183. PubMed ID: 28903883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different types of upper extremity exercise training in Duchenne muscular dystrophy: effects on functional performance, strength, endurance, and ambulation.
    Alemdaroğlu I; Karaduman A; Yilmaz ÖT; Topaloğlu H
    Muscle Nerve; 2015 May; 51(5):697-705. PubMed ID: 25196721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lower extremity surgery in muscular dystrophy.
    Griffet J; Decrocq L; Rauscent H; Richelme C; Fournier M
    Orthop Traumatol Surg Res; 2011 Oct; 97(6):634-8. PubMed ID: 21924694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of lower extremity range of motion and muscle strength with physical performance of community-dwelling older women.
    Jung H; Yamasaki M
    J Physiol Anthropol; 2016 Dec; 35(1):30. PubMed ID: 27931244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of Contractures in DMD in Relation to MRI-Determined Muscle Quality and Ambulatory Function.
    Willcocks RJ; Barnard AM; Wortman RJ; Senesac CR; Lott DJ; Harrington AT; Zilke KL; Forbes SC; Rooney WD; Wang DJ; Finanger EL; Tennekoon GI; Daniels MJ; Triplett WT; Walter GA; Vandenborne K
    J Neuromuscul Dis; 2022; 9(2):289-302. PubMed ID: 35124659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ankle contractures and functional motor decline in Duchenne muscular dystrophy.
    Woof AL; Selby K; Harris SR
    Brain Dev; 2022 Feb; 44(2):105-113. PubMed ID: 34629214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of ambulatory capacity and disease progression of Duchenne muscular dystrophy subjects enrolled in the drisapersen DMD114673 study with a matched natural history cohort of subjects on daily corticosteroids.
    Goemans N; Tulinius M; Kroksmark AK; Wilson R; van den Hauwe M; Campion G
    Neuromuscul Disord; 2017 Mar; 27(3):203-213. PubMed ID: 28169120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical trial readiness in non-ambulatory boys and men with duchenne muscular dystrophy: MDA-DMD network follow-up.
    Connolly AM; Florence JM; Zaidman CM; Golumbek PT; Mendell JR; Flanigan KM; Karachunski PI; Day JW; McDonald CM; Darras BT; Kang PB; Siener CA; Gadeken RK; Anand P; Schierbecker JR; Malkus EC; Lowes LP; Alfano LN; Johnson L; Nicorici A; Kelecic JM; Quigley J; Pasternak AE; Miller JP;
    Muscle Nerve; 2016 Oct; 54(4):681-9. PubMed ID: 26930423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.